| P2093 | author name string | Nujen Colak Bozkurt | |
| | Mustafa Ozbek | |
| | Evrim Cakır | |
| | Basak Karbek | |
| | Melia Karakose | |
| | Muyesser Sayki Aslan | |
| | Oya Topaloglu | |
| | Tuncay Delibasi | |
| P2860 | cites work | Science review: Vasopressin and the cardiovascular system part 1--receptor physiology | Q21195090 |
| | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| | C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 |
| | Copeptin: clinical use of a new biomarker | Q34010057 |
| | Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 |
| | Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 |
| | Clinical assessment of body hair growth in women | Q34252149 |
| | Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome | Q34288567 |
| | Polycystic ovary syndrome and cardiovascular disease: a premature association? | Q35146315 |
| | Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction | Q35569452 |
| | The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. | Q35961894 |
| | The impact of obesity on reproduction in women with polycystic ovary syndrome | Q36530364 |
| | Plasma copeptin and the risk of diabetes mellitus | Q37147707 |
| | High Prevalence of Diabetes in Adana, a Southern Province of Turkey | Q39667990 |
| | Plasma copeptin, a unifying factor behind the metabolic syndrome | Q39760962 |
| | The nature of the hepatic receptors involved in vasopressin-induced glycogenolysis | Q40265349 |
| | Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions | Q42141857 |
| | Altered vascular function in young women with polycystic ovary syndrome | Q42166330 |
| | Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas | Q42525305 |
| | Low grade chronic inflammation in women with polycystic ovarian syndrome | Q43633815 |
| | Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort | Q43684302 |
| | Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? | Q44289368 |
| | A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization | Q44580290 |
| | The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study | Q45005999 |
| | C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study | Q46061278 |
| | Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 |
| | Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure | Q48399609 |
| | Induction of Oxidative Stress and Human Leukocyte/Endothelial Cell Interactions in Polycystic Ovary Syndrome Patients with Insulin Resistance | Q60692204 |
| | Polycystic ovary syndrome | Q80844876 |
| | Cardiovascular risk in women with polycystic ovary syndrome | Q81984578 |
| | Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease | Q83342800 |
| | [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?] | Q84376182 |
| P921 | main subject | circulatory system | Q11068 |
| | AVP | Q12009087 |
| | polycystic ovary syndrome | Q500816 |
| | polycystic ovary | Q5547896 |
| P304 | page(s) | 31 | |
| P577 | publication date | 2014-03-14 | |
| P1433 | published in | Journal of Ovarian Research | Q27721898 |
| P1476 | title | Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome | |
| P478 | volume | 7 | |